| Q34690684 | Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease |
| Q34222246 | Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B. |
| Q33990270 | Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content. |
| Q33352124 | Body mass index and the efficacy of acid-mediating agents for GERD. |
| Q55154163 | Co-exposure to benzo[a]pyrene and ethanol induces a pathological progression of liver steatosis in vitro and in vivo. |
| Q36449625 | Comparison of first-year results of tenofovir and entecavir treatments of nucleos(t)ide-naive chronic hepatitis B patients with hepatosteatosis |
| Q44606344 | De Novo Non-Alcoholic Fatty Liver Disease Following Orthotopic Liver Transplantation |
| Q35825142 | Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans |
| Q37120909 | Drug metabolism alterations in nonalcoholic fatty liver disease |
| Q44650830 | Effect of two 5-HT6 receptor antagonists on the rat liver: a molecular approach |
| Q43041127 | Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors |
| Q83821267 | Hepatic CYP3A expression is attenuated in obese mice fed a high-fat diet |
| Q39578297 | Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG cells |
| Q72995518 | Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis |
| Q44583413 | Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats |
| Q34359458 | Pregnane X Receptor and Constitutive Androstane Receptor at the Crossroads of Drug Metabolism and Energy Metabolism |
| Q35087638 | Serum alanine transaminase total bilirubin concentrations predict CYP3A activity as measured by midazolam and 1'-hydroxylation |
| Q42995637 | Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patients |
| Q47201124 | Steatosis in chronic hepatitis C: can weight reduction improve therapeutic efficacy? |
| Q44307870 | The combined effects of garlic oil and fish oil on the hepatic antioxidant and drug-metabolizing enzymes of rats |
| Q37854751 | The effects of obesity on drug pharmacokinetics in humans |